Lupin Steps On Peptide Levers While Pegfilgrastim Nears Launch

Hikes EBIDTA Guidance

 
• By Vibha Ravi
  
Lupin's growth strategy leverages peptides, biosimilars
Lupin's growth strategy leverages peptides, biosimilars (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business